Pacific biosciences of california stock.

April 11, 2023 at 12:00 PM · 4 min read. Pacific Biosciences of California (PACB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in ...The notes will have a conversion price of $43.50 per share of the company's common stock, representing a 10% premium over Pacific Biosciences' share price as of the end of yesterday's trading session.Pacific Biosciences Of California reported $68.26M in Stock for its fiscal quarter ending in September of 2023. Data for Pacific Biosciences Of California ...A steep rise in short interest was recorded in Pacific Biosciences of California Inc stocks on Oct 30, 2023, growing by 2.05 million shares to a total of 35.12 million shares. Yahoo Finance data shows the prior-month short interest on Sep 28, 2023 was 33.07 million shares. There was a rise of 5.84%, which implies that there is a …Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Home. Mail; News; Sports; Finance; ... Pacific Biosciences of California, Inc. (PACB) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Add to watchlist. 8.55 +0.19 (+2.27%)

Raised approximately $201 million in gross proceeds in an upsized public offering of common stock in January 2023. ... Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve …If you live in California, chances are you get your electricity and gas services from Pacific Gas and Electric Company (PG&E). As a PG&E customer, you receive a monthly bill for your energy usage.

Pacific Biosciences of California Inc stock has a Value Score of 8, Growth Score of 57 and Quality Score of 12. Comparing Inmode Ltd and Pacific Biosciences of California Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset ...

Asia Pacific; CORPORATE INQUIRIES ... California 6965 Lusk Boulevard San Diego, CA 92121 USA ... United Kingdom Rolling Stock Yard 188 York Way London, N7 9AS UK ... Pacific Biosciences of California Stock Forecast 11-26-2023. Forecast target price for 11-26-2023: $ 8.02. Negative dynamics for Pacific Biosciences of California shares will prevail with possible volatility of 5.469%. Pessimistic target level: 7.80.١٦‏/٠٨‏/٢٠٢٣ ... Why Pacific Biosciences of California Inc's (PACB) Stock Is Down 4.55% ... One of the most dreaded feelings for an investor is when the stock they ...The stock price of Pacific Biosciences of California, a biotechnology company that develops gene sequencing systems, has seen a large fall of 38% over the last twenty-one trading days, while it is ...

Jan 24, 2023 · Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems.

Apr 21, 2023 · Valuation for Pacific Biosciences In 2023, the firm anticipates generating revenues in the range of $165 million to $180 million, reflecting a 29% to 40% increase. During the fourth quarter, 76 ... Nov 28, 2023 · In other Pacific Biosciences of California news, insider Christian O. Henry sold 96,844 shares of the stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $10.12, for a total value of $980,061.28. A steep rise in short interest was recorded in Pacific Biosciences of California Inc stocks on Oct 30, 2023, growing by 2.05 million shares to a total of 35.12 million shares. Yahoo Finance data shows the prior-month short interest on Sep 28, 2023 was 33.07 million shares. There was a rise of 5.84%, which implies that there is a …Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Let’s take a look at how Pacific Biosciences of California Inc’s stock performed this quarter. Earnings: $-0.28 per share, versus the consensus estimate of $-0.32 per share, according to AAII’s Stock Investor Pro, Refinitiv and I/B/E/S. Revenue: $39 million, versus $33 million in the same period one year ago.

Track Pacific Biosciences of California Inc (PACB) Stock Price, Quote, latest community messages, chart, news and other stock related information.Mar 31, 2023 · Pacific Biosciences of California Inc’s price is currently up 27.53% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $11.79 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85. Pacific Biosciences of California Inc (PACB). Industry Medical Devices. Deal. This stock can be held in an Investment ISA and an Investment Account. Sell. $6.55.The notes will have a conversion price of $43.50 per share of the company's common stock, representing a 10% premium over Pacific Biosciences' share price as of the end of yesterday's trading session.Stock Lists Headlines About Pacific Biosciences of California Stock Price, News & Analysis (NASDAQ:PACB) $8.55 +0.19 …

Pacific Biosciences of California Stock Up 4.7 %. Pacific Biosciences of California stock opened at $8.88 on Friday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 4.43 and a ...Currently, the analyst consensus on Pacific Biosciences is a Hold with an average price target of $11.40. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $14.20 and a ...

The average twelve-month price prediction for Pacific Biosciences of California is $11.80 with a high price target of $17.00 and a low price target of $8.00. Learn more on PACB's analyst rating history. Do Wall Street analysts like Pacific Biosciences of California more than its competitors?Pacific Biosciences of California Inc. published this content on 15 November 2022 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 15 November 2022 20:01:02 UTC .Mar 31, 2023 · Pacific Biosciences of California Inc’s price is currently up 27.53% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $11.79 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85. Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares stood at 3.89 million during the last session, with the company’s beta value hitting 1.76. At the close of trading, the stock’s price was $8.36, to imply an increase of 0.97% or $0.08 in intraday trading.Pacific Biosciences of California Stock Up 2.3 %. Shares of NASDAQ:PACB opened at $8.55 on Friday. The company has a debt-to-equity ratio of 1.17, a current ratio of 4.80 and a quick ratio of 4.43.Legal Name Pacific Biosciences of California, Inc. Stock Symbol NASDAQ:PACB. Company Type For Profit. Contact Email [email protected]. Phone Number 650-618-2699. PacBio designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its single molecule real-time (SMRT) sequencing technology enables ...The five states that border the Pacific Ocean are California, Oregon, Washington, Alaska and Hawaii. The proximity of the states to the Pacific Ocean affects their climate. Along the coast, temperatures vary by as much as 19 degrees Fahrenh...

A steep rise in short interest was recorded in Pacific Biosciences of California Inc stocks on Oct 30, 2023, growing by 2.05 million shares to a total of 35.12 million shares. Yahoo Finance data shows the prior-month short interest on Sep 28, 2023 was 33.07 million shares. There was a rise of 5.84%, which implies that there is a …

Pacific Biosciences of California Inc. PACB (U.S.: Nasdaq) Pacific Biosciences of California Inc. View All companies. REAL TIME 12:47 PM EST 11/30/23. $8.62 USD.

A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its trailing twelve months earnings. ... Pacific Biosciences of California rises after UBS upgrades on strong 'Revio ...Traveling by car offers a sense of freedom and adventure that is hard to replicate with other modes of transportation. The Pacific Coast Highway, also known as Highway 1, stretches for over 600 miles along the stunning coastline of Californ...MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering. PacBio also intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 …Pacific Biosciences of California Inc (NASDAQ: PACB) has seen a rise in its stock price by 10.74 in relation to its previous close of 6.52. However, the company has experienced a 1.55% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-10-31 that PacBio (PACB) witnesses strong revenue growth in ...Nov 29, 2023 · See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions. PACB Stock Summary and Trading Ideas (Pacific Biosciences Of California | NASDAQ:PACB) · Trade Ideas for Best Option Strategies for PACB by Theoretical Edge and ...The notes will have a conversion price of $43.50 per share of the company's common stock, representing a 10% premium over Pacific Biosciences' share price as of the end of yesterday's trading session.Pacific Biosciences of California (NASDAQ:PACB) rose 3.16% Friday pre-market after UBS upgraded the sequencing systems company on a strong "Revio" demand. Revio system is a product with long-read ...Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 …Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 11:18PM. Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock.Pacific Biosciences of California Inc’s ( PACB) price is currently up 16.83% so far this month. During the month of November, Pacific Biosciences of California Inc’s stock price has reached a high of $7.45 and a low of $5.74. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low …

Pacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025 [email protected] Email Alerts The Investor Relations website contains information …Pacific Biosciences (PACB) delivered earnings and revenue surprises of 6.06% and 10.55%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?Instagram:https://instagram. wine collection for saleetf that pay monthly dividendshow to learn day tradingnasdaq usoi Pacific Biosciences of California Revenue Forecast for 2023 - 2025 - 2030. Pacific Biosciences of California's Revenue has grown In the last three years, rising from $90.89M to $128.30M – a growth of 41.16%. In the next year, analysts believe that Revenue will reach $196.94M – an increase of 53.50%. For the next nine years, experts predict ...Nov 15, 2022 · Pacific Biosciences of California Inc. published this content on 15 November 2022 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 15 November 2022 20:01:02 UTC . apple shortbest indicators to use for day trading Nov 27, 2023 · The average twelve-month price prediction for Pacific Biosciences of California is $11.80 with a high price target of $17.00 and a low price target of $8.00. Learn more on PACB's analyst rating history. Do Wall Street analysts like Pacific Biosciences of California more than its competitors? Pacific Biosciences of California is forecast to grow earnings and revenue by 30.8% and 30.6% per annum respectively. EPS is expected to grow by 33.7% per annum. Return on equity is forecast to be -58.8% in 3 years. moomoo trading review April 11, 2023 at 12:00 PM · 4 min read. Pacific Biosciences of California (PACB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in ...MENLO PARK, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, highly accurate sequencing platforms, today announced a partnership with The European Reference Genome Atlas (ERGA) consortium to support …